Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 273-9400

Roberto J Firpi-Morell, MD, MS : Research

Gastroenterologist, Transplant Hepatologist

Additional languages:
Spanish
Photo of Roberto J Firpi-Morell
(352) 273-9400 MyUFHealth

Research at a glance

Top areas of exploration

  • Liver Transplantation , 20 publications
  • Hepatitis C , 17 publications
  • Recurrence , 13 publications
  • Liver Cirrhosis , 13 publications

Research activity

91 publications

2,378 citations

Why is this important?

Active clinical trials

TARGET NASH

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within…

Investigator
Roberto J Firpi-Morell
Status
Accepting Candidates
Ages
2 Years - N/A
Sexes
All

My publications

91 publications

2023

Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

PubMed • Publisher's site

2022

Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

PubMed • Publisher's site

2021

Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease.

Digestive diseases (Basel, Switzerland)

PubMed • Publisher's site

2020

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.

Diabetes care

PubMed • Publisher's site

2019

Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study.

Clinical and translational gastroenterology

PubMed • Publisher's site